This finding is consistent with the expression profiles of JMJD6 APA isoforms in normal and tumor samples from cancer patients, suggesting that cancer cells maximize the expression of the short form of JMJD6, which functions as an oncogene. This evidence concerns the gene JMJD6 and neoplasm.